Cargando…
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family
BACKGROUND: miR-200b has been reported to be a tumor suppressor and a promising therapeutic target in cancer. miR-200b has been associated with epithelial-mesenchymal transition and chemo-resistance in cancer. The aim of this study is to investigate the expression of miR-200b, its prognostic roles a...
Autores principales: | Ye, Feng, Tang, Hailin, Liu, Qing, Xie, Xinhua, Wu, Minqing, Liu, Xiaoping, Chen, Bo, Xie, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898994/ https://www.ncbi.nlm.nih.gov/pubmed/24447584 http://dx.doi.org/10.1186/1479-5876-12-17 |
Ejemplares similares
-
miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015) -
MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013) -
Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013) -
miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019) -
Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
por: Choi, Pui-Wah, et al.
Publicado: (2020)